Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2018-2023
Since the introduction of generic drugs in 2001, Brazil’s pharmaceutical industry has undergone a transformation. Generic drugs have been continuously gaining market share and currently account for a significant share of the total pharmaceutical market in Brazil. According to estimates, around BRL 2 Billion worth of branded drugs are expected to lose patent protection during the next five years. The high potential of generic drugs is also driven by the fact that despite strong growth in recent years, the penetration of generics still remains low compared to mature markets such as Germany, the United States, the United Kingdom, etc. These factors along with a rising ageing population, increasing prevalence of life style diseases and the significant cost savings achieved from the use of generic drugs are expected to drive this market during the next five years.
The report entitled “Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2018-2023” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Brazil. This research report serves as an exceptional tool to understand the drivers, sales trends, volume trends, market structure, competitive landscape, regulations, key players, manufacturing and the outlook of generic drugs in Brazil. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the market for generic drugs in Brazil.
Key Questions Answered in this Report:
What are generic drugs, how are they different from branded drugs? How has the generic drug market performed in recent years? How have generics performed compared to branded drugs? What were the total sales and volumes of generic drugs in Brazil? Who are the key players in Brazil generic drug market? What is the structure of the generic drug market in Brazil? What is the pricing mechanism of generic drugs in Brazil? What is the value chain of generic drugs in Brazil? What are the regulations for generic drugs in Brazil? How are generic drugs distributed in Brazil? How are generic drugs manufactured? What are the drivers and challenges in the generic drugs market in Brazil?